RSS Feeds
Search

Companies

Companies

Displaying 1..1 of 1 - per page
Order by
Decision Resources Inc.
The worldwide leader in market research publications, advisory services and consulting More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Multiple Myeloma: Revlimid in the U.S. Market
Jan 2008 - $2,500
Multiple Myeloma - Pipeline Review, Q3 2011
Jul 2011 - 386 pages - $500
Post- American Society of Hematology Annual Meeting (ASH) Survey 2007
Dec 2007 - $2,500
Multiple Myeloma Therapeutics Clinical Trials Review, Q4, 2010
Nov 2010 - 92 pages - $1,000
Multiple Myeloma: Revlimid in the European Market
Dec 2007 - $2,500
Multiple Myeloma Research Foundation (MMRF) - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Multiple Myeloma Therapy Area Pipeline Report
Nov 2010 - 790 pages - $1,495
Epigenetics Therapeutics to 2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma
Sep 2010 - 89 pages - $3,500
Multiple Myeloma Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Oct 2011 - 111 pages - $3,500
Multiple Myeloma Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Dec 2010 - 47 pages - $2,000
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us